Angioedema

Common Name(s)

Angioedema

Description for this condition is not yet available.
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Angioedema" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
Top

How do you compare to others with this condition?

Privately answer questions about your health. Let resources, you select, come to you.

Anonymously share and see how your answers compare with others with this condition while privately providing key pieces of information to medical researchers, disease advocacy groups, and others ONLY YOU select to help speed up cures and better alternatives.

 
 

Advocacy and Support Organizations

 

Condition Specific Organizations

Following organizations serve the condition "Angioedema" for support, advocacy or research.

There are currently no organizations listed in Disease InfoSearch that support this condition. Create a listing.

 

 

General Support Organizations

Not finding the support you need? Show General Support Organizations

 
 
 
 
Top

Scientific Literature

Articles from the PubMed Database

Research articles describe the outcome of a single study. They are the published results of original research.
The terms "Angioedema" returned 282 free, full-text research articles on human participants. First 3 results:

Icatibant in ACE-inhibitor-induced angioedema.
 

Author(s): Murat Baş, Thomas K Hoffmann, Georg Kojda

Journal: N. Engl. J. Med.. 2015 May;372(19):1867-8.

 

Last Updated: 7 May 2015

Go To URL
Treatment with icatibant in the management of drug induced angioedema.
 

Author(s): G Bertazzoni, E Bresciani, L Cipollone, E Fante, R Galandrini

Journal: Eur Rev Med Pharmacol Sci. 2015 Jan;19(1):149-53.

 

Acute, drug-induced angioedema may not respond to standard therapies, because the pathogenetic mechanism that induces the pathology is not always mediated by histamine but, in certain instances, by bradykinin. A case of angioedema is reported here, in which allergic etiology was excluded ...

Last Updated: 31 Jan 2015

Go To URL
A randomized trial of icatibant in ACE-inhibitor-induced angioedema.
 

Author(s): Murat Baş, Jens Greve, Klaus Stelter, Miriam Havel, Ulrich Strassen, Nicole Rotter, Johannes Veit, Beate Schossow, Alexander Hapfelmeier, Victoria Kehl, Georg Kojda, Thomas K Hoffmann

Journal: N. Engl. J. Med.. 2015 Jan;372(5):418-25.

 

Angioedema induced by treatment with angiotensin-converting-enzyme (ACE) inhibitors accounts for one third of angioedema cases in the emergency room; it is usually manifested in the upper airway and the head and neck region. There is no approved treatment for this potentially life-threatening ...

Last Updated: 29 Jan 2015

Go To URL

Reviews from the PubMed Database

Review articles summarize what is currently known about a disease. They discuss research previously published by others.
The terms "Angioedema" returned 33 free, full-text review articles on human participants. First 3 results:

Diagnosis and treatment of bradykinin-mediated angioedema: outcomes from an angioedema expert consensus meeting.
 

Author(s): Timothy J Craig, Jonathan A Bernstein, Henriette Farkas, Laurence Bouillet, Isabelle Boccon-Gibod

Journal: Int. Arch. Allergy Immunol.. 2014 ;165(2):119-27.

 

Several types of angioedema exist beyond hereditary angioedema (HAE) types I/II; however, the diagnostic and treatment needs of these conditions are not well understood. Noticeably, there are no licensed treatments available for other forms of angioedema beyond HAE types I/II, and ...

Last Updated: 23 Dec 2014

Go To URL
Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.
 

Author(s): M Wadelius, S E Marshall, G Islander, L Nordang, M Karawajczyk, Q-Y Yue, I Terreehorst, E V Baranova, S Hugosson, K Sköldefors, M Pirmohamed, A-H Maitland-van der Zee, A Alfirevic, P Hallberg, C N A Palmer

Journal: Clin. Pharmacol. Ther.. 2014 Oct;96(4):477-81.

 

Angioedema is a potentially life-threatening adverse reaction to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers. To study the genetic etiology of this rare adverse event, international consortia and multicenter recruitment of patients are needed. To reduce ...

Last Updated: 19 Sep 2014

Go To URL
A consensus parameter for the evaluation and management of angioedema in the emergency department.
 

Author(s): Joseph J Moellman, Jonathan A Bernstein, Christopher Lindsell, Aleena Banerji, Paula J Busse, Carlos A Camargo, Sean P Collins, Timothy J Craig, William R Lumry, Richard Nowak, Jesse M Pines, Ali S Raja, Marc Riedl, Michael J Ward, Bruce L Zuraw, Deborah Diercks, Brian Hiestand, Ronna L Campbell, Sandra Schneider, Richard Sinert, ,

Journal: Acad Emerg Med. 2014 Apr;21(4):469-84.

 

Despite its relatively common occurrence and life-threatening potential, the management of angioedema in the emergency department (ED) is lacking in terms of a structured approach. It is paramount to distinguish the different etiologies of angioedema from one another and more specifically ...

Last Updated: 15 Apr 2014

Go To URL
 
 
Top

Symptoms, Diagnosis, and Treatment

There are currently no related results available in GeneReviews.

There are currently no related results available in Genetic Testing Registry.

 
 
Top

Clinical Trial Information This information is provided by ClinicalTrials.gov

Safety of Ruconest in 2-13 Year Old Hereditary Angioedema (HAE) Patients
 

Status: Recruiting

Condition Summary: Hereditary Angioedema

 

Last Updated: 28 Jul 2015

Go to URL
Study to Assess the Tolerability and Safety of Ecallantide in Children and Adolescents With Hereditary Angioedema
 

Status: Recruiting

Condition Summary: Hereditary Angioedema Types I and II

 

Last Updated: 23 Sep 2014

Go to URL

Last Updated: 12 Mar 2015

Go to URL